ABHD2 and ovarian carcinoma: In accordance with this result, in two expression microarray datasets of ovarian cancer consisting mostly of HGSOC (GSE9891, GSE3149), the prognosis of the low ABHD2 expression group was significantly worse as compared to that of the high ABHD2 expression group (p=0.013, p=0.04, respectively, Figure 8b).